Stay updated with breaking news from Nasdaq Pacb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its target price trimmed by Sanford C. Bernstein from $9.00 to $2.50 in a research note released on Thursday morning, Benzinga reports. The firm currently has an outperform rating on the biotechnology company’s stock. A number of other equities research analysts have also recently commented on […]
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report)’s share price gapped up before the market opened on Monday . The stock had previously closed at $3.68, but opened at $3.81. Pacific Biosciences of California shares last traded at $3.69, with a volume of 590,328 shares traded. Analysts Set New Price Targets Several equities […]
Nordea Investment Management AB raised its position in Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) by 37.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 149,131 shares of the biotechnology company’s stock after purchasing an additional 40,667 shares during the quarter. […]
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) insider Oene Mark Van sold 33,560 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $5.96, for a total transaction of $200,017.60. Following the completion of the transaction, the insider now owns 876,611 […]
Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $5.27 and last traded at $5.33, with a volume of 1917605 shares. The stock had previously closed at $5.74. Analyst Upgrades and Downgrades A number of […]